Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate. npj Parkinson's Disease , 2024; 10 (1) DOI: 10.1038/s41531-024-00788-x Cite This Page : ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression. According ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Parkinson’s patients in Sheffield and London are taking part in a clinical trial led by NIHR Sheffield Biomedical Research Centre to test a drug, for the first time, which could slow progression of ...
A drug which has been used to treat liver disease for over 30 years is being trialled in patients with Parkinson’s Disease and will assess its potential to slow down disease progression for the first ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Is there anything I can do to lower my risk of developing Parkinson’s disease? Parkinson’s disease affects over 8.5 million people globally and is rising at an alarming rate: By 2030 ...